Apoptosis of peripheral blood lymphocytes in Parkinson patients

Neurobiology of Disease

Volumn 38, Issue 1, 2010, Pages 1-7

  Calopa, Màtil ^a   Bas, Jordi ^a   Callén, Antonio ^a   Mestre, Mariona ^a  

^a Hospital Universitari   (Spain)

Author keywords

Annexin V; Apoptosis; CD95; Fas; Lymphocytes; Parkinson's disease

Indexed keywords

AMANTADINE; ANTIPARKINSON AGENT; BIPERIDEN; DOPAMINE RECEPTOR STIMULATING AGENT; FAS ANTIGEN; LEVODOPA; LIPOCORTIN 5; SELEGILINE;

ADULT; AGED; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DEGENERATIVE DISEASE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IDIOPATHIC DISEASE; MAJOR CLINICAL STUDY; PARKINSON DISEASE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

AGED; ANNEXIN A5; ANTIGENS, CD95; APOPTOSIS; BINDING, COMPETITIVE; BIOLOGICAL MARKERS; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; COHORT STUDIES; FEMALE; FLOW CYTOMETRY; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; NERVE DEGENERATION; NEURONS; PARKINSON DISEASE;

EID: 77549083834     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2009.12.017     Document Type: Article

References (39)

1. Alcouffe J., et al. Expression of membrane-bound and soluble FasL in Fas- and FADD-dependent T lymphocyte apoptosis induced by mildly oxidized LDL. FASEB J. 18 (2004) 122-124
2. Andersen J.K. Oxidative stress in neurodegeneration: cause or consequence?. Nat. Med. 10 suppl (2004) S18-S25
3. Bas J., et al. Lymphocyte populations in Parkinson's disease and in rat models of parkinsonism. J. Neuroimmunol. 113 (2001) 146-152
4. Battisti C., et al. Oxidative-stress-induced apoptosis in PBLs of two patients with Parkinson disease secondary to alpha-synuclein mutation. J. Neurol. Sci. 267 (2008) 120-124
5. Blandini F., et al. Peripheral proteasome and caspase activity in Parkinson disease and Alzheimer disease. Neurology 66 (2006) 529-534
6. + lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. J. Clin. Invest. 119 (2009) 182-192
7. Brunner T., et al. Fas (CD95/Apo-1) ligand regulation in T cell homeostasis, cell-mediated cytotoxicity and immune pathology. Semin. Immunol. 15 (2003) 167-176
8. Chin M.H., et al. Mitochondrial dysfunction, oxidative stress, and apoptosis revealed by proteomic and transcriptomic analyses of the striata in two mouse models of Parkinson's disease. J. Proteome Res. 7 (2008) 666-677
9. Dexter D.T., et al. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J. Neurochem. 52 (1989) 381-389
10. Eckert A., et al. Lymphocytes as cell model to study apoptosis in Alzheimer's disease: vulnerability to programmed cell death appears to be altered. J. Neural. Transm. Suppl. 54 (1998) 259-267
11. Eriksen J.L., et al. Molecular pathogenesis of Parkinson disease. Arch. Neurol. 62 (2005) 353-357
12. Good P.F., et al. Protein nitration in Parkinson's disease. J. Neuropathol. Exp. Neurol. 57 (1998) 338-342
13. Hartmann A., et al. FADD: a link between TNF family receptors and caspases in Parkinson's disease. Neurology 58 (2002) 308-310
14. Hartmann A., et al. Increased expression and redistribution of the antiapoptotic molecule Bcl-xL in Parkinson's disease. Neurobiol. Dis. 10 (2002) 28-32
15. Hughes A.J., et al. A clinico-pathologic study of 100 cases of Parkinson's disease. Arch. Neurol. 50 (1993) 140-148
16. Iglesias J., et al. CD95 expression and function on lymphocyte subpopulations in common variable immunodeficiency (CVID); related to increased apoptosis. Clin. Exp. Immunol. 117 (1999) 138-146
17. Jenner P., and Olanow C.W. The pathogenesis of cell death in Parkinson's disease. Neurology 66 Suppl 4 (2006) S24-S36
18. Jimenez Del Rio M., et al. Autosomal recessive juvenile parkinsonism Cys212Tyr mutation in parkin renders lymphocytes susceptible to dopamine- and iron-mediated apoptosis. Mov. Disord. 19 (2004) 324-330
19. Kim S., et al. α-Synuclein induces apoptosis by altered expression in human peripheral lymphocytes in Parkinson's disease. FASEB J. 18 (2004) 1615-1617
20. McGeer P.L., and McGeer E.G. Glial reactions in Parkinson's disease. Mov. Disord. 23 (2008) 474-483
21. Mochizuki H., et al. Histochemical detection of apoptosis in Parkinson's disease. J.Neurol. Sci. 137 (1996) 120-123
22. Mogi M., et al. The soluble form of Fas molecule is elevated in parkinsonian brain tissues. Neurosci. Lett. 220 (1996) 195-198
23. Müftüoglu M., et al. Mitochondrial complex I and IV activities in leukocytes from patients with parkin mutations. Mov. Disord. 19 (2003) 544-579
24. Nair V.D., et al. p53 mediates nontranscriptional cell death in dopaminergic cells in response to proteasome inhibition. J. Biol. Chem. 281 (2006) 39550-39560
25. Olanow C.W. Can we achieve neuroprotection with currently available anti-parkinsonian interventions?. Neurology 72 Suppl 2 (2009) S59-S64
26. Petrozzi L., et al. Cytogenetic analysis oxidative damage in lymphocytes of Parkinson's disease patients. Neurol. Sci. 22 (2001) 83-84
27. Phelouzat M.A., et al. Susceptibility to apoptosis of T lymphocytes is associated with increased in vivo expression of functional Fas receptors. Mech. Ageing Dev. 96 (1997) 35-46
28. Prigione A., et al. Oxidative stress in peripheral blood mononuclear cells from patients with Parkinson's disease: negative correlation with levodopa dosage. Neurobiol. Dis. 23 (2006) 36-43
29. Romeu M.A., et al. Lymphocyte immunophenotyping by flow cytometry in normal adults. Comparison of fresh whole blood lysis technique, Ficoll-Paque separation and cryopreservation. J. Immunol. Methods 154 (1992) 7-10
30. Rosenkranz D., et al. Higher frequency of regulatory T cells in the elderly and increased suppressive activity in neurodegeneration. J. Neuroimmunol. 188 (2007) 117-127
31. + T lymphocytes in peripheral blood of patients with advanced melanoma. Clin. Cancer Res. 6 (2000) 1351-1364
32. Schaefer S., et al. Pituitary function and the somatotrophic system in patients with idiopathic Parkinson's disease under chronic dopaminergic therapy. J. Neuroendocrinology. 20 (2008) 104-109
33. Schubert R., et al. Spontaneous and oxidative stress-induced programmed cell death in lymphocytes from patients with ataxia telangiectasia (AT). Clin. Exp. Immunol. 119 (2000) 140-147
34. Sofic E., et al. Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease. Neurosci. Lett. 142 (1992) 128-130
35. Tatton N.A. Increased caspase 3 and Bax immunoreactivity accompany nuclear GAPDH translocation and neuronal apoptosis in Parkinson's disease. Exp. Neurol. 166 (2000) 29-43
36. Tatton W.G., et al. Apoptosis in Parkinson's disease: signals for neuronal degradation. Ann. Neurol. 53 Suppl 3 (2003) S61-S70
37. Thiery J., et al. p53 potentiation of tumor cell susceptibility to CTL involves Fas and mitochondrial pathways. J. Immunol. 174, (2005) 871-878
38. Vermes I., et al. Flow cytometry of apoptotic cell death. J. Immunol. Methods 243 (2000) 167-190
39. Waring P., and Mullbacher A. Cell death induced by the Fas/Fas ligand pathway and its role in pathology. Immunol. Cell Biol. 77 (1999) 312-317